Multispectral and computational methods reveal secalonic acid F binds to human serum albumin, suggesting therapeutic potential.
Secalonic acid F (SAF) is a fungal secondary metabolite with broad pharmacological activities. This study investigated the interaction mechanism between SAF and HSA through multispectral techniques, molecular docking, and molecular dynamics simulations. The results show that SAF effectively reduces the intrinsic fluorescence of HSA through static quenching and forms a stable 1:1 molar ratio SAF-HSA complex. SAF binds to the second domain site of HSA. The binding reaction is a spontaneous, exothermic process driven by enthalpy, mainly stabilized through hydrogen bonds and van der Waals forces. Spectral analysis confirmed an increase in the α-helical structure of HSA upon binding. Molecular docking and molecular dynamics simulations, including analyses of RMSD, RMSF, and Rg, further supported and elucidated the experimental results.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: